V
310210
vs
K
KOSPI 200
Over the past 12 months, Voronoi Inc has outperformed KOSPI 200, delivering a return of +148% compared to the KOSPI 200's +123% growth.
Stocks Performance
310210 vs KOSPI 200
Performance Gap
310210 vs KOSPI 200
Performance By Year
310210 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Voronoi Inc
Glance View
Voronoi, Inc. engages in the manufacture of novel kinase inhibitors and target protein degrader drugs. The company is headquartered in Incheon, Incheon. The company went IPO on 2022-06-24. The firm is principally engaged in the technology transfer of new drug candidates prior to electroclinical clinical trials. The firm is principally engaged in the research and development of kinase inhibitor as well as others. In addition, the Company is also engaged in the building and supply of new drug development platforms based on artificial intelligence (AI) and research results.
